Trial intelligence / Profile preview

Dexmedetomidine Supplemented Analgesia for Postoperative Delirium in Elderly Cancer Surgery Patients

NCT03012984Completed

Sponsor
Peking University First Hospital
Start
Jan 2017
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in delirium (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of delirium within 5 days after surgery. Started Jan 2017; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

delirium

Beyond the preview

Go deeper on NCT03012984.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03012984.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call